Independent guides to CBD, CBN and CBG products, labels, lab reports and brand trade-offs—built to separate merchant claims from verifiable product facts.
Some links are affiliate links. If you buy through them, we may earn a commission at no extra cost to you.
A fact-checked look at the current catalog, testing claims, formats, strengths and who should compare alternatives.
How to compare serving strength, spectrum, THC content, COAs and total cost without treating a bigger milligram number as automatically better.
A restrained overview of what these cannabinoids are, what evidence can and cannot establish, and how products differ.
Cannabinoid product pages often mix measurable facts—milligrams, ingredients, spectrum and lab reports—with wellness language. Cannabinoid Compass keeps those categories separate and links to primary or official sources when safety claims matter.
The FDA says it has approved only one prescription CBD product for specific seizure disorders and continues to warn about potential liver injury, drug interactions, side effects and unknowns around non-approved CBD products.
Read the FDA consumer update →Compare testing, gummy types, cannabinoid blends and manufacturing positioning.
Compare potency, full-spectrum formulas, sleep gummies and lab-report access.
Compare THC-free options, organic positioning, potency and testing transparency.